In vivo CRISPR screening reveals epigenetic regulators of hepatobiliary plasticity
Genes & Development · 01.05.2025 · 39 (9-10) · 603-616
DOI: 10.1101/gad.352420.124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Development, online erschienen am 01.04.2025. Verfasst von Jonathan H Sussman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Cellular Reprogramming, Liver, Clustered Regularly Interspaced Short Palindromic Repeats. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NICHD NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Following prolonged liver injury, a small fraction of hepatocytes undergoes reprogramming to become cholangiocytes or biliary epithelial cells (BECs). This physiological process involves chromatin and transcriptional remodeling, but the epigenetic mediators are largely unknown. Here, we exploited a lineage-traced model of liver injury to investigate the role of histone post-translational modification in biliary reprogramming. Using mass spectrometry, we defined the repertoire of histone marks that are globally altered in quantity during reprogramming. Next, applying an in vivo CRISPR screening approach, we identified seven histone-modifying enzymes that alter the efficiency of hepatobiliary reprogramming. Among these, the histone methyltransferase and demethylase Nsd1 and Kdm2a were found to have reciprocal effects on H3K36 methylation that regulated the early and late stages of reprogramming, respectively. Although loss of Nsd1 and Kdm2a affected reprogramming efficiency, cells ultimately acquired the same transcriptomic states. These findings reveal that multiple chromatin regulators exert dynamic and complementary activities to achieve robust cell fate switching, serving as a model for the cell identity changes that occur in various forms of physiological metaplasia or reprogramming.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
- Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
- Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
- Graduate Group in Genomics and Computational Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
- Penn Epigenetics Institute, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA; tkatsuda412@gmail.com bstanger@upenn.edu.
ORCID-Profile: Jonathan H Sussman, Ben Z Stanger, Takeshi Katsuda
Förderung
- NCI NIH HHS
- NICHD NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
- Fred and Suzanne Biesecker Pediatric Liver Center
- Abramson Family Cancer Research Institute
- International Medical Research Foundation
- Daiichi Sankyo Foundation of Life Science
Zitieren
APA
Sussman, J. H., Cure, H. W., Yuan, S., Ito, K., Asangani, I. A., Garcia, B. A., Stanger, B. Z., & Katsuda, T. (2025). In vivo CRISPR screening reveals epigenetic regulators of hepatobiliary plasticity. Genes & Development, 39(9-10), 603-616. https://doi.org/10.1101/gad.352420.124
Vancouver
Sussman JH, Cure HW, Yuan S, Ito K, Asangani IA, Garcia BA, et al. In vivo CRISPR screening reveals epigenetic regulators of hepatobiliary plasticity. Genes & Development. 2025;39(9-10):603-616. doi:10.1101/gad.352420.124
BibTeX
@article{Sussman2025,
author = {Sussman, Jonathan H and Cure, Hector W and Yuan, Salina and Ito, Kenji and Asangani, Irfan A and Garcia, Benjamin A and Stanger, Ben Z and Katsuda, Takeshi},
title = {In vivo CRISPR screening reveals epigenetic regulators of hepatobiliary plasticity},
journal = {Genes & Development},
year = {2025},
volume = {39},
number = {9-10},
pages = {603--616},
doi = {10.1101/gad.352420.124}
}
EUVIMED